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Abstract
During nervous system development different cell-to-cell communication mechanisms operate in parallel guiding migrating
neurons and growing axons to generate complex arrays of neural circuits. How such a system works in coordination is not
well understood. Cross-regulatory interactions between different signalling pathways and redundancy between them can
increase precision and fidelity of guidance systems. Immunoglobulin superfamily proteins of the NCAM and L1 families
couple specific substrate recognition and cell adhesion with the activation of receptor tyrosine kinases. Thus it has been
shown that L1CAM-mediated cell adhesion promotes the activation of the EGFR (erbB1) from Drosophila to humans. Here
we explore the specificity of the molecular interaction between L1CAM and the erbB receptor family. We show that L1CAM
binds physically erbB receptors in both heterologous systems and the mammalian developing brain. Different Ig-like
domains located in the extracellular part of L1CAM can support this interaction. Interestingly, binding of L1CAM to erbB
enhances its response to neuregulins. During development this may synergize with the activation of erbB receptors through
L1CAM homophilic interactions, conferring diffusible neuregulins specificity for cells or axons that interact with the
substrate through L1CAM.
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Introduction
Immunoglobulin superfamily proteins are key players in the
developmental mechanisms of metazoans. Two of them, NCAM
and L1CAM, are involved in the control of morphogenesis,
axon growth and guidance, and synaptic plasticity; but they
have also other functions in and outside the nervous system.
L1CAM behaves as an adhesion molecule in cell-aggregation
assays. However L1CAM is more than a specific glue and
serves as well as an activator of intracellular signaling pathways
[1,2,3,4]. L1CAM couples the highly specific recognition
interaction mediated by homophilic adhesion with the activation
of the EGFR (also known as erbB1). Thus, it has been reported
that human-L1CAM homophilic adhesion promotes human-
EGFR activation in transfected Drosophila-Schneider S2 cells
[3]. This activity requires both homophilic binding and the
expression of EGFR in the same cell, suggesting it is mediated
by cis-interactions. During Drosophila development, the function
of L1CAM (Neuroglian) is mediated by the EGFR, as revealed
by the rescue of Neuroglian loss-of-function phenotype by
activated-EGFR [4] and the suppression of Neuroglian gain-of-
function phenotype by the loss of EGFR activity [3].The
specificity of L1CAM as an activator of EGFR signaling has
been conserved during the 500 million of years of evolution that
separate Drosophila from human [5,6]. The interaction of
L1CAM with distinct molecular partners and the domains
involved in these interactions have been well established [7,8].
In contrast, it has not been possible to find evidence of physical
binding between L1CAM and the EGFR, what could reflect a
low affinity in the interaction [3]. Here we show evidence for
this binding. We found that L1CAM, through the Ig-like
domains, physically interacts with erbB receptors in heterolo-
gous systems. We also show evidences of the in vivo interaction
of L1CAM with erbB receptors in the developing brain.
Furthermore, we found that the interaction between L1CAM
and erbB proteins strongly enhance the response of these
receptors to their ligand neuregulin. Together with previous
reports, our results support the view that the L1CAM-erbB
interaction is an ancestral evolutionary-conserved mechanism
that modulates erbB signaling. We propose this mechanism
serves to increase the specificity of the neuregulin/erbB-
signaling pathway, enhancing its precision and robustness for
the control of cell migration and axon guidance during nervous
system development.
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Results and Discussion
L1CAM Physically Interacts with erbB Receptors in
Heterologous Systems
It has been previously shown that human L1CAM-mediated
homophilic cell interactions can activate the human EGFR
tyrosine kynase activity in Drosophila S2 cells [3]. To explore if
this is consequence of the interaction between both proteins in the
plasma membrane, we checked whether L1CAM could physically
bind the EGFR. To this aim, we subcloned the cDNA encoding
for the human L1CAM (isoform 2) into the pcDNA3 mammalian
expression vector (see Material and Methods section). Then, we
co-transfected this construct and the pcDNA6A-EGFR (a vector
that expresses the human EGFR with a myc epitope [9]) into the
human embryonic kidney cells HEK293. Cells were trypsinized,
harvested by centrifugation and lysed. Supernatants were incu-
bated with anti-L1CAM monoclonal antibody prebound to
protein A sepharose and immunoprecipated. Proteins were
released and submitted to anti-myc western blot analysis. As
shown in Figure 1a, myc immunoreactivity was pulled down from
cells expressing L1CAM and EGFR, suggesting that both proteins
physically interact when expressed in heterologous systems. The
specificity of the immunoprecipitation (IP) was demonstrated by
the absence of myc immunoreactivity pulled down from the cells
that express the EGFR alone. To confirm this result, the reverse
co-immunoprecipitation was performed. As is shown in Figure 1b,
immunoprecipitation with anti-myc antibody was able to pull
down L1CAM in cells that express EGFR. No immunoreactivity
was detected when the EGFR was omitted. Together, these results
demonstrate that L1CAM physically interacts with the EGFR in
HEK293 cells.
EGFR belongs to the family of erbB receptors [10]. Four types
of erbB receptors (erbB1-erbB4) that recognize different ligands
have been described [11]. EGFR binds the epidermal growth
factor (EGF), while erbB3 and erbB4 recognize members of the
neuregulin family of proteins. Neuregulin binding to the erbB3
and erbB4 receptors induces heterodimerization with erbB2
receptor, which has a strong tyrosine kinase activity (but does
not interact with known ligands). To explore whether L1CAM can
also interact with other members of the mammalian erbB tyrosine
kinase receptor family we co-transfected pcDNA3-L1CAM and
pcDNA3-erbB2 into HEK293 cells. Cells were harvested, lysed
and immunoprecipated with the anti-L1CAM antibody as
described previously. As it is shown in Figure 1c, erbB2 receptor
co-immunoprecipitated with L1CAM. The specificity of the assay
was demonstrated by the absence of immunoreactivity immuno-
precipitated from cells that express only erbB2 but not L1CAM.
As before, to verify the interaction, the reverse experiment was
performed. As is shown in Figure 1d, immunoprecipitation of
erbB2 pulled down L1CAM, showing that L1CAM and erbB2
receptor are physically bound when expressed in HEK293 cells.
No immunoreactivity was detected when erbB2 was omitted. A
similar approach was used with the erbB3 receptor. As shown,
L1CAM was also able to physically interact with erbB3 in
HEK293 cells (Figure 1e and 1f). Thus far, our data show that
L1CAM physically interacts with different members of the erbB
family of tyrosine kinase receptors when expressed in vertebrate
heterologous systems.
In vivo Interaction of L1CAM and erbB3
Having determined that L1CAM can interact with different
erbB receptors by co-IP assays, we decided to study whether the
interaction occurs in intact cells in vivo by using the proximity
ligation assay (PLA, see methods) [12]. To this aim, HEK293 cells
were co-transfected with similar amounts of pcDNA-L1CAM and
pcDNA-erbB3 plasmids. A smaller amount (1:10) of a plasmid
encoding for the green fluorescent protein was added to allow the
identification of transfected cells. The interaction of L1CAM and
erbB3 in vivo was determined using specific antibodies for each
protein raised in different species and the ‘‘Duolink in situ’’
technology. As is shown in Figure 1g, a strong interaction signal
(red dots) was observed only in transfected cells (GFP+) but not in
non-transfected ones (GFP-). Thus far, our results demonstrated
that L1CAM interacts with erbB3 in intact cells when expressed in
heterlogous systems. PLA results also support a cis-interaction
between L1CAM and erbB3, as we found strong signal in isolated
cells where the L1CAM homophilic binding in trans is not
possible.
L1CAM is expressed in different mammalian tissues where it is
involved in many biological and pathological processes. One of
these tissues is the nervous system [7], where L1CAM is pivotal for
axon guidance and axon-glia interactions. Interestingly, neuregu-
lin receptors are also highly expressed in the nervous system [13]
being central for many aspects of its development [14]. Based on
this we decided to explore whether L1CAM and neuregulin
receptors physically interact in the nervous system in vivo. First we
explored if L1CAM and erbB receptors are co-expressed. As
shown in Figure 1 h, L1CAM strongly co-localizes with the EGFR
in the growing axons of the developing mammalian brain, whereas
much less co-localization was found with the non-related protein
Notch 2. Interestingly, there is also a high degree of L1CAM co-
localization with erbB2 and erbB3 receptors (Figure 1 h). The co-
localization was also observed in the corpus callosum of P3 mice
(Figure S1). Our previous data in heterologous systems and the
high degree of colocalization strongly suggested the possibility of
the in vivo interaction between L1CAM and the members of the
erbB family of proteins. To check this hypothesis, brain extracts
from P2 rats were immunoprecipitated with anti-erbB3 antibody
and immunoblotted with the monoclonal anti-L1CAM antibody.
To stabilize the interaction before IP we used DTBP, a cleavable,
bifunctional, imidoester crosslinker (see Material and Methods). As
is shown in Figure 1i, endogenously expressed L1CAM co-
immunoprecipitates with erbB3 suggesting that both proteins
physically interact in the developing brain. L1CAM co-immuno-
precipitated as well with the erbB2 receptor from brain extracts
(Fig 1j). However, we couldn’t detect L1CAM-EGFR co-
immunoprecipitation (not shown), possibly reflecting a regulated
protein-protein interaction. Nevertheless, it could be also conse-
quence of technical problems related with the affinity of the
interaction and/or the quality of the antibodies used for these
studies. To confirm our observations, we explored the in vivo
interaction of L1CAM and erbB3 by the PLA. As is shown in
Figure S2, protein-protein interaction signal was observed in a
subpopulation of cortical neurons at E14. These cells may
correspond to previously identified L1CAM positive neurons in
the marginal zone of the mouse developing brain. [15]. We
couldn’t detect interaction in the growing axons possibly because
the level of interacting proteins in these structures is below the
limit of the PLA.
In summary our results show that L1CAM co-localizes and
physically interacts with different members of the erbB family of
proteins in the developing mammalian brain.
The Ig-like Domains but not the Fibronectin Type III
Repeats Determine L1CAM Interaction with erbB3
The N-terminal domain of L1CAM consists of the Ig domains
1–6 followed by the fibronectin type III repeats 1–5. It has been
shown that L1CAM specifically interacts with other partner
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proteins through different sequences of this extracellular domain
[7,8]. On this basis we decided to explore if the interaction of
L1CAM with erbB receptors is mediated by some specific
sequence in this part of the protein. First we removed the
sequence encoding for the six Ig-like domains in the pcDNA3-
L1CAM construct. The resulting deleted protein will be referred
as DIg-L1CAM. We used a similar approach to remove the
fibronectin type III repeats 1–5 (referred as DFn-L1CAM). Then
we explored if the interaction with erbB receptors is preserved in
these mutants. To this aim we co-transfected each of these
constructs with erbB3 into HEK293 cells, and then performed co-
immunoprecipitation assays as described previously. As it is shown
in Figure 2a, truncated proteins of the expected molecular size can
be immunoprecipitated from transfected cells (lower panel).
Interestingly, whereas the DFn-L1CAM truncated protein retains
its capacity to interact with erbB3, the elimination of the six Ig-like
domains from the extracellular region (DIg-L1CAM) completely
abrogates the capacity of L1CAM to interact with the erbB3
receptor. To rule out that deletions in L1CAM could produce
sorting defects that prevent co-localization with erbB3, cells were
transiently transfected with the L1CAM constructs and the
pcDNA3-erbB3 vector. The expression and subcellular localiza-
tion of L1CAM constructs and erbB3 was followed by immuno-
fluorescence. As is shown in Figure 2b and c, both DIg-L1CAM
and DFn-L1CAM truncated proteins were normally expressed,
and co-localized almost perfectly with the erbB3 receptor, ruling
out a sorting defect. Taken together our results indicate that some
sequence in the Ig-like domain region of L1CAM mediates the
interaction with erbB receptors.
Different Ig-like Domains Support the Interaction of
L1CAM with erbB3
To further characterize the specific sequence responsible for
the interaction between L1CAM and erbB receptors we adopted
a stepwise strategy. We started removing the Ig-like domains 1 to
3 (construct DIg1-3-L1CAM) and then the 4 to 6 in a different
construct (DIg4-6-L1CAM). We first explored the expression of
these proteins by immunofluorescence. As shown in Figure 3a,
both truncated proteins are normally expressed and co-localize
with erbB3. Then we co-transfected these truncated proteins, the
full length L1CAM and the DIg-L1CAM construct, with erbB3
into HEK293 cells. Cells were lysed and the extracts immuno-
Figure 1. Physical interaction of L1CAM with erbB receptors. a) L1CAM co-immunoprecipitates with erbB1 (EGFR): a pcDNA3 plasmid
containing the cDNA encoding for human L1CAM and the pcDNA6A-EGFR construct were transiently co-transfected into the HEK293 cells. 48 h later
cells were homogenized and L1CAM immunoprecipitated (IP). Immunoprecipitates were resolved by SDS-PAGE and blotted with anti-myc antibody
to detect EGFR. As is shown, EGFR was pulled down only in L1CAM expressing cells. EGFR expression was similar in both extracts (input). Immunoblot
with anti-L1CAM shows that this protein was correctly immunoprecipitated. b) Reverse co-immunoprecipitation. IP with anti-myc antibody pulls
down L1CAM only in EGFR transfected cells. L1CAM expression was similar in both extracts (input). Immunoblot with anti-myc shows that the EGFR
was correctly immunoprecipitated. c) L1CAM co-immunoprecipitates with erbB2: pcDNA3-L1CAM and the pcDNA3-erbB2 were transiently co-
transfected into the HEK293 cells. Extracts were immunoprecipitated with the anti-L1CAM antibody. erbB2 was pulled down only in L1CAM
expressing cells. erbB2 expression was similar in both extracts (input). Anti-L1CAM immunoblot shows that this protein was correctly
immunoprecipitated. d) Reverse co-immunoprecipitation. IP with anti-erbB2 antibody pulls down L1CAM only in erbB2 transfected cells. L1CAM
expression was similar in both extracts (input). Anti-erbB2 WB shows that erbB2 was correctly immunoprecipitated. e) erbB3 co-immunoprecipitates
with L1CAM: pcDNA3-L1CAM and the pcDNA3-erbB3 were transiently co-transfected. Extracts were immunoprecipitated with the anti-L1CAM
antibody. erbB3 was pulled down only in L1CAM expressing cells. erbB3 expression was similar in both extracts (input). Anti-L1CAM immunoblot
shows that this protein was correctly immunoprecipitated. f) Reverse co-immunoprecipitation. IP with anti-erbB3 antibody pulls down L1CAM only in
erbB3 transfected cells. L1CAM expression was similar in both extracts (input). Anti-myc WB shows that erbB3 was correctly immunoprecipitated. g)
Proximity ligation assay showing L1CAM-erbB3 in vivo interaction. HEK293 cells were enforced to express L1CAM and erbB3. To identify the
transfected cells, a plasmid encoding GFP was included. As is shown, only the transfected cells (green) were positive for the PLA signal (red). Note that
the interaction signal can be detected in cells that are not in contact with other transfected cells, showing that the interaction between L1CAM and
erbB3 is produced in cis. Scale bars represent 20 mm. h) L1CAM (red) co-localizes with EGFR (erbB1), erbB2 and erbB3 (green) in growing axons during
brain development (at E14). Images at the right correspond to the co-localization channel (white). Co-localization is evident in cortical projections.
Poor co-localization of L1-CAM was detected with Notch 2, used as a control for specificity. Co-localization was revealed with the ImageJ software and
the Co-localization Finder plugin (for co-localization at P3 stage see the Figure S1). Images show coronal sections of E14 mouse brain incubated with
the indicated antibodies and acquired at low magnification wide-field fluorescence (at left) or higher magnification under the confocal microscope.
Scale bars correspond to 100 mm. i) L1CAM physically interacts with erbB3 in vivo. Whole brains of two days old rats were homogenized in RIPA buffer
clarified by centrifugation and cross-linked with DTBP. Supernatants were immunoprecipitated with the anti-erbB3 antibody and blotted with anti-
L1CAM. As a control of specificity an aliquot of the extract was immunoprecipitated with a non-specific anti-IgG. As shown, L1CAM was pulled down
when immunoprecipitation was performed with the anti-erbB3 but not with the anti-IgG. Input shows that L1CAM is abundantly expressed in the P2
rat brains. IgG bands demonstrate a similar loading of immunoprecipitated proteins. This experiment was repeated 5 times. A representative
experiment is shown. j) A similar result was obtained with the receptor erbB2.
doi:10.1371/journal.pone.0040674.g001
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precipitated with anti-L1CAM monoclonal antibody. As shown
in Figure 3b, erbB3 co-immunoprecipitates with the DIg1-3-
L1CAM construct, suggesting that the sequence that mediates
L1CAM binding with erbB receptors lies in this region.
However, and to our surprise, erbB3 was also able to co-
immunoprecipitate with the DIg4-6L1CAM truncated protein.
As expected, erbB3 did not co-immunoprecipitate with the
construct that lacks the whole Ig-like region (DIg-L1CAM). Thus
far our results show that different Ig-like domains of L1CAM can
support the interaction with erbB receptors. Given the non-
quantitative nature of our assay, we cannot rule out the existence
of distinct Ig-like domain sequences with different affinities for
erbB receptors. Interestingly the presence of erbB binding
activity in the different Ig-like domains of L1CAM is consistent
with the reported capacity of the vertebrate protein to activate
Drosophila EGFR, as the Ig-like domains are well preserved
between L1CAM and Neuroglian [5,6]. This strongly suggests
that the specificity of the physical interaction may reside in some
general feature of the Ig-like domains and sheds light on why this
may also happen for NCAM-type proteins, which have as well
Ig-like domains [5]. Such a generic mechanism of interaction
may be the reason why this type of erbB receptor control is
strongly conserved during evolution.
L1CAM-erbB Interaction Modulates Neuregulin Receptor
Activation
Upon neuregulin binding erbB intracellular domain becomes
autophosphorylated and recruits cytosolic proteins that activate
intracellular signalling pathways [16,17]. Although initially iden-
tified as a cell adhesion molecule, L1CAM has been shown to be
pivotal for cell-to-cell signalling in different biological contexts
[8,18,19,20]. As it has been introduced previously, human
L1CAM-mediated homophilic cell interactions activate the human
EGFR tyrosine kynase activity in Drosophila S2 cells [3]. With this
in mind, we reasoned that the physical interaction with L1CAM
could modulate the sensitivity of erbB receptors to activation by
ligands. To explore this hypothesis we used the cell line MCF-7, a
breast cancer cell that expresses endogenously erbB2 and erbB3
receptors [21]. First we transiently transfected MCF-7 cells with
the cDNA encoding for the full length L1CAM. The enforced
expression of L1CAM produces no changes in the expression of
endogenous erbB3 (Fig S3). Then cells were challenged with
neuregulin. As a control we transfected MCF-7 cells with the
empty vector (pcDNA3). Cells were harvested and the activation
status of erbB receptors explored. In MCF-7 cells this can be done
in immunoblots by determining the amount of anti-phosphotyr-
osine immunoreactivity in the < 180 kDa region [9,22,23,24]. As
shown in Figure 4a, enforced L1CAM expression increased the
phosphorylation in tyrosines of the 180 kDa band, suggesting that
physical interaction between L1CAM and erbB2/erbB3 sensitizes
the receptor complex to the activation by neuregulins. To test this
hypothesis we transfected MCF-7 cells with DIg-L1CAM, the
truncated protein that, as shown in the previous points, is unable
to interact with erbB3. As it is shown in Figure 4b, the ablation of
the Ig-like domain region completely abrogates the capacity of
L1CAM to sensitize the erbB2/erbB3 complex to neuregulins.
Taken together, our data shows that the physical interaction of
L1CAM with neuregulin receptors modulates the response of erbB
proteins to ligands and suggests a role of the interaction in the
regulation of the intracellular signalling cascades elicited by these
proteins. Note that our experiments are performed in cultures with
a low degree of confluence, where the cis-interactions predominate
over trans-interactions. Also, the interaction of L1CAM with erbB3
can occur in ‘‘isolated’’ cells where the L1CAM mediated
homophilic cell adhesion is not possible (Figure 1g). Therefore,
our results strongly suggest that it is the interaction of L1CAM and
erbB in cis what sensitizes these receptors for neuregulin signalling.
However, we do not rule out that L1CAM homophilic binding
could also modulate the cis-interactions of L1CAM and erbB
receptors in confluent cultures.
Development of complex tissues like the nervous system relies
on the deployment of many different cell-cell communication
processes in parallel. It is likely that mechanisms coupling specific
substrate recognition and adhesion with signalling by attractants
Figure 2. The Ig-like domains but not the fibronectin repeats of L1CAM mediate the physical interaction with erbB receptors. a)
Ablation of Ig-like domains abrogates L1CAM interaction with erbB3: HEK293 cells were transfected with pcDNA3-erbB3 and the different truncated
forms of L1CAM. Cell extracts were immunoprecipitated with anti-L1CAM antibody and blotted against erbB3. As is shown, erbB3 was pulled down
when co-expressed with the full length and DFn-L1CAM constructs, but not when was co-expressed with the DIg-L1CAM construct. As expected, anti-
L1CAM antibody does not immunoprecipate cells transfected with pcDNA3-erbB3 exclusively. Input lanes demonstrate the expression of erbB3 in the
extracts. An aliquot of the immunoprecipitate was probed with anti-L1CAM to verify the adequate immunoprecipitation of the truncated proteins.
IgG bands show that a similar amount of immunoprecipitate was loaded. This experiment was repeated three times. A representative experiment is
shown. b) To rule out sorting problems that could explain the absence of co-IP, L1CAM and deleted constructs were co-transfected with erbB3 in
COS-7 cells. As is shown, the distribution of L1CAM, DIg-L1CAM and DFn-L1CAM is similar when transfected into HEK293 cells, being detectable in the
plasma membrane. c) The co-localization of the deleted constructs and full length L1CAM with erbB3 was nearly complete, ruling out sorting defects
for the mutant proteins. L1CAM was detected with the anti-L1CAM monoclonal antibody (green) and erbB3 with a polyclonal antibody (red). Nuclei
were counterstained with the Hoechst stain (blue). Co-localization (white) was revealed with the ImageJ software and the Co-localization Finder
plugin.
doi:10.1371/journal.pone.0040674.g002
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and repellents help to increase the precision and robustness of cell
migration, axon guidance, target recognition and synaptogenesis.
Indeed, this may be the reason why the L1CAM Ig-like domain
interaction with erbB receptors is a mechanism preserved during
more than half billion years of metazoan evolution.
Material and Methods
Materials
Pfu turbo DNA polymerase and BL21 codon plus E. coli
strain were from Stratagene. HRP-conjugated anti-rabbit IgG
and anti-mouse IgG secondary antibodies, monoclonal antipho-
sphotyrosine (clone PT-66) were obtained from SIGMA. Anti-
L1CAM monoclonal antibody (ab24345) and anti-IgG poly-
clonal antibody (ab27478) were from Abcam. Anti-erbB3 (C-17;
sc-285) polyclonal antibody was from Santa Cruz Biotechnol-
ogy. Anti-erbB2 (29D8) polyclonal antibody and anti-EGFR
(C74B9) were from Cell Signalling. ECL+plus was from
Amersham biosciences. Lipofectamine 2000 was obtained from
Invitrogen. The pcDNA3-erbB2 and pcDNA3-erbB3 vectors
were kindly provided by Professor Yossef Yarden (The
Figure 3. Different Ig-like domains can support L1CAMphysical interaction with erbB receptors. a) Truncated proteins DIg1-3L1CAM and
DIg4-6L1CAM are normally expressed and distributed when transfected into COS-7 cells. High magnification confocal images of cells transiently
transfectedwith the indicated constructs are shown. L1CAMwas detectedwith an anti-L1CAMmonoclonal antibody (green) and erbB3with a polyclonal
antibody (red). Nuclei were counterstained with the Hoechst stain (blue). As is shown both deletionmutants of L1CAM co-localize with erbB3 (white). b)
Ablation of Ig-like domains 1 to 3 or 4 to 6 does not abrogate L1CAM interaction with erbB3: HEK293 cells were transfected with pcDNA3-erbB3 and the
different truncated forms of L1CAM. Cell extracts were immunoprecipitated with anti-L1CAM antibody and blotted against erbB3. As shown, erbB3 was
pulled downwhen co-expressedwithDIg1-3L1CAM,DIg4-6L1CAMand full-length constructs but notwhen co-expressedwith theDIg-L1CAMconstruct.
As expected, anti-L1CAM antibody does not immunoprecipitate erbB3 in cells transfected with pcDNA3-erbB3 exclusively. Input lanes demonstrate the
expression of erbB3 in the extracts. An aliquot of the immunoprecipitated was probed with anti-L1CAM to verify the adequate expression and
immunoprecipitationof the truncatedproteins. IgGbands show that a similar amount of immunoprecipitatedwas loaded. This experimentwas repeated
twice. A representative experiment is shown.
doi:10.1371/journal.pone.0040674.g003
Figure 4. L1CAM-erbB interaction enhances neuregulin induced phosphorylation of erbB3. a) Upper panel: MCF-7 cells were transiently
transfected with pcDNA3-L1CAM or pcDNA3 empty vector. 24 h later, cells were serum starved and stimulated with recombinant NRG1 (50 nM) for
15 min. Then, cells were harvested and lysed. Extracts were submitted to SDS-PAGE and blotted with anti-p-Tyr monoclonal antibody or anti-erbB3
polyclonal antibody. This experiment was repeated three times. A representative experiment is shown. Lower panel: the same approach was used in
cells transfected with the DIg-L1CAM truncated construct. This experiment was repeated twice. One of them is shown. b) Quantification of western
blots by densitometry. The normalized amount of phosphorylated 180 kDa band is increased in cells that express the full length but not the
truncated DIg-L1CAM protein, suggesting that the physical interaction of L1CAM and erbB3 is needed for the enhancing effect on neuregulin
receptor activation. Bars represent standard errors c) Proposed model: the interaction with L1CAM sensitizes erbB receptors to the activation by
neuregulins. Removing the Ig-like rich region of L1CAM prevents the interaction and avoids receptor sensitization. For simplicity, only cis-interactions
are depicted in the model.
doi:10.1371/journal.pone.0040674.g004
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Weizmann Institute of Science, Rehovot, Israel). pcDNA6A-
EGFR was obtained from MC Hung (University of Texas M.D.
Anderson Cancer Center, Houston, USA) [9].
Subcloning of L1CAM and production of deletions. The
cDNA encoding for the human L1CAM (isoform 2) was subcloned
into the pcDNA3 vector. This construct was used as a template to
obtain the pcDNA3-L1CAM DIg and DFn constructs and variants
by standard molecular biology techniques.
Cell lines, culture and transfections. HEK293 and MCF-
7 cells (both from ATCC-LGC) were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) containing 10% of foetal
bovine serum. Cells were plated on 2 cm2 wells at 250.000 cells/
well. Twenty hours later, cells were transfected with 1 mg of
plasmid DNA using lipofectamine 2000 following the manufac-
turer recommendations. MCF-7 cells were cultured in DMEM
containing 10% of foetal bovine serum.
Tyrosine phosphorylation assay. Neuregulin-induced ty-
rosine phosphorylation of erbB receptors was carried out as
described previously [9,22,23,24]. Briefly, MCF-7 cells were
grown until $80% confluence in 24–well plates. Thereafter, cells
were serum-starved for 2–5 h and incubated with recombinant
neuregulin for 15 minutes at room temperature as indicated.
Medium was removed and cells were harvested and homogenized
in RIPA buffer. Whole cell extracts were heat denatured,
separated by SDS-PAGE, and analyzed by immunoblotting with
the monoclonal anti-phosphotyrosine antibody (1:1,000). Purifica-
tion of the recombinant neuregulin from E. coli was performed as
described elsewhere [25]. Protein concentration was calculated
with the method of Bradford [26] or BCA (Pierce).
Immunofluorescence. Cells were seeded on cover-slips and
transfected with the indicated vectors. Primary antibody (anti-
L1CAM at 1:1000) was diluted in 1% goat serum and 0.3% Triton
X-100 in PBS and incubated overnight at 4uC. Cover-slips were
then washed with PBS, and detection was performed using the
fluorescent secondary antibody anti-mouse AlexaFluor 488
(Invitrogen) at 1:700 dilution for 1 h. Nuclei were counterstained
with bisbenzimide (Hoechst nuclear stain) in PBS. Samples were
mounted in Fluoromount G (Southern Biotechnology Associates).
For tissue immunofluorescence we obtained 30–50 mm floating-
sections from embryonic and P3 mouse brains. Primary antibodies
were used at dilutions: mouse anti-L1CAM, 1:300; rabbit anti-
EGFR, 1:100; rabbit anti-erbB2, 1:100 and rabbit anti-erbB3,
1:100. We used Cy2- and Cy3-coupled secondary antibodies from
Jackson ImmunoResearch. DAPI was used to stain nuclei in the
brain sections. Images were obtained using a confocal ultraspectral
microscope (Leica TCS SP2).
Co-immunoprecipitation. HEK293 cells were transfected
with Lipofectamine 2000 according to the manufacturer’s
instructions. 24 h post-transfection, cells were lysed (lysis buffer:
50 mM Tris, 150 mM NaCl, 2 mM EDTA, protease inhibitor
cocktail (Complete Mini, Roche), 0.5% Triton X-100) and
incubated 1 h on ice. Cell lysate was centrifuged 10 min at 4uC,
and an aliquot of the supernatant was kept aside on ice (‘‘input’’).
Protein A-Sepharose beads (GE Healthcare) were loaded with the
primary antibody for 1 h at room temperature and washed 3 times
with PBS. Cell lysate supernatant was mixed with antibody-loaded
beads, and incubated 3 h on ice, with mild shaking. Beads were
washed 4 times with ice-cold PBS, resuspended in SDS sample
buffer, boiled 5 min, and loaded onto a 7% acrylamide gel. The
proteins were transferred to nitrocellulose membrane (Protran,
Whatman GmbH). The membrane was blocked with 5% BSA in
TBS containing 0.1% Tween and incubated with the indicated
antibody in blocking buffer overnight at 4uC. The membrane was
then washed three times with TBS containing 0.1% Tween, and
the secondary antibody (horseradish peroxidase-conjugated) was
applied at 1:2000 dilution in TBS containing 0.1% Tween for 2 h
at room temperature. Immunoreactivity was detected using ECL
Plus detection reagent (GE Healthcare). A similar protocol was
used with the brains removed from euthanized P2 rats. In this
case, the interaction of the proteins was stabilized with the
cleavable, bifunctional, imidoester crosslinker DTBP (3 mM,
45 min) befote IP.
Proximity ligation assay (PLA). The in situ PLA method
allows determine the subcellular localization of protein–protein
interactions. Oligonucleotides attached to antibodies against two
target proteins guide the formation of circular DNA strands when
bound in close proximity. The DNA circles serve as templates for
localized rolling-circle amplification, allowing individual interact-
ing pairs of protein molecules to be visualized [12]. HEK293 cells
transfected with the pcDNA3-L1CAM, pcDNA3-erbB3 and
pEGFP were seeded on coverslips, fixed and processed with the
Duolink In Situ kit (OLINK Bioscience) as recommended by
manufacturer. Duo-link was used with the primary antibodies
mouse anti-L1CAM and rabbit anti-erbB3. Secondary anti-mouse
and anti-rabbit antibodies attached to oligonucleotides were used
as proximity probes. After hybridization, ligation and amplifica-
tion, a detection solution containing a fluorescent probe was
added. Fluorescent spots were then visualized by confocal
microscopy. Negative controls were non-transfected cells. The
same approach was used with E14 mouse brain free-floating
sections.
Ethics statement. To avoid suffering animals were pro-
foundly anesthetized before euthanasia. All animal work has
been conducted according to EU guidelines and with protocols
approved by the ‘‘Comite´ de Bioe´tica y Bioseguridad del
Instituto de Neurociencias de Alicante UMH-CSIC’’ (http://in.
umh.es/).
Supporting Information
Figure S1 Expression of EGFR erbB2 and erbB3 recep-
tors (in green) and L1CAM (in red) in P3 mouse brain.
L1CAM co-localizes with EGFR, erbB2 and erbB3 in the Corpus
Callosum of P3 mouse brain. Low magnification is shown in left
panels and high magnification in middle panels. Images at right
correspond to the co-localization channel (white). Co-localization
is evident in the callosal tract at P3. Poor co-localization of
L1CAM with Notch 2 can be observed. Co-localization was
revealed with ImageJ software and the Co-localization Finder
plugin.
(PDF)
Figure S2 PLA performed on free-floating sections from
E14 mouse brain confirmed in vivo the interaction of
L1CAM with erbB3. A group of neurons in the cortex gave a
strong PLA signal (red). Nuclei were counterstained with the
Hoechst staining. These neurons were tentatively identified as
‘‘pioneer neurons’’ by the expression of L1CAM and the
topographical localization in the E14 cortex (see text). However,
we couldn’t detect interaction signal in the axons. Bar represent
40 mm.
(PDF)
Figure S3 a) L1CAM enforced expression doesn’t
change the expression levels of the endogenous erbB3
or erbB2 expression in MCF-7 cells. MCF-7 cells were
transiently transfected with the pcDNA3-L1CAM expression
vector. 24 h later, cells were immunostained for L1CAM (green)
and erbB3 (red). Nuclei were counterstained with the Hoechst
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nuclear stain. As is shown, no differences in endogenous erbB3
expression can observed in those cells that have been transfected
with L1CAM. b) The same result was obtained for the DIg-
L1CAM construct. c) Levels of erbB2 were also non-changed by
the expression of L1CAM.
(PDF)
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